LEXXW fundamentals
An in-depth look to Lexaria Bioscience Corp. operating, investing, and financing activities
LEXXW free cash flow for Q3 24 is -1.27 M USD. For 2023, LEXXW free cash flow was -5.91 M USD and operating cash flow was -5.88 M USD.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q1 '24
Q2 '24
Q3 '24
TTM